CM
HRMY icon

Caption Management’s Harmony Biosciences HRMY Stock Holding History

Caption Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14M Buy
+500,000
New +$16.4M 0.08% 264
2025
Q4 		– Sell
-26,500
Closed -$730K – 1798
2025
Q3 		$730K Buy
+26,500
New +$913K 0.01% 1203

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Caption Management's HRMY Position: Q1 2026 in Review

Caption Management opened a new position in Harmony Biosciences (HRMY) in Q1 2026: 272,292 shares worth $7.63M. The stake represents 0.04% of the portfolio and ranks #407 among its holdings. This is a return to the name: Caption Management previously reported a position in HRMY as recently as Q3 2023.

Caption Management first reported a position in HRMY in Q1 2023 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Caption Management held 272,292 shares of Harmony Biosciences worth $7.63M as of Q1 2026.
  • Harmony Biosciences was a new Caption Management position in Q1 2026.
  • Harmony Biosciences made up 0.04% of Caption Management's portfolio in Q1 2026, its #407 holding.
  • Caption Management first reported a position in Harmony Biosciences in Q1 2023 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.